Physician-scientist awarded two grants to develop immune therapies for ovarian cancer

New research aims to provide new treatment strategies for women impacted by hard-to-treat and often fatal type of ovarian cancer
Dr. Sanaz Memarzadeh
Dr. Sanaz Memarzadeh, professor of obstetrics and gynecology and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, and collaborating colleagues are leading a team of researchers to develop new treatment approaches for women impacted by high grade serous ovarian cancer.